HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qing Lin Selected Research

laminarin sulfate

9/2021Enhanced anti-metastatic therapy with down-regulation of heparinase expression by ROS-responsive micellar nanoparticles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qing Lin Research Topics

Disease

58Neoplasms (Cancer)
01/2022 - 10/2002
21Inflammation (Inflammations)
01/2021 - 10/2003
14Breast Neoplasms (Breast Cancer)
04/2022 - 10/2007
14Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 08/2012
9Neurogenic Inflammation
09/2015 - 02/2003
7Adenocarcinoma
01/2022 - 08/2015
7Neoplasm Metastasis (Metastasis)
01/2022 - 05/2004
6Hypoxia (Hypoxemia)
04/2022 - 07/2007
6Body Weight (Weight, Body)
01/2022 - 12/2005
6Carcinogenesis
02/2019 - 05/2004
6Hepatocellular Carcinoma (Hepatoma)
02/2019 - 02/2007
5Reperfusion Injury
12/2021 - 06/2017
5Brain Ischemia (Cerebral Ischemia)
12/2021 - 12/2015
5Nasopharyngeal Carcinoma
10/2021 - 07/2005
5Carcinoma (Carcinomatosis)
07/2018 - 11/2003
5Wounds and Injuries (Trauma)
01/2016 - 03/2011
5Infections
05/2015 - 05/2011
5Seizures (Absence Seizure)
09/2014 - 04/2008
5Pain (Aches)
09/2013 - 11/2004
5Necrosis
07/2012 - 04/2004
4Ischemia
04/2022 - 09/2007
4Epilepsy (Aura)
12/2020 - 01/2003
4Type 2 Diabetes Mellitus (MODY)
03/2020 - 09/2007
4Fibrosis (Cirrhosis)
01/2020 - 10/2008
4Cholangiocarcinoma
10/2013 - 05/2011
4Edema (Dropsy)
09/2013 - 06/2006
4Pulmonary Fibrosis (Fibrosing Alveolitis)
04/2010 - 10/2009
3Triple Negative Breast Neoplasms
01/2022 - 01/2013
3Obesity
01/2022 - 10/2009
3Rupture
01/2022 - 12/2009
3Pancreatic Fistula (Pancreatic Fistulas)
12/2021 - 12/2012
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2021 - 12/2015
3Melanoma (Melanoma, Malignant)
09/2021 - 05/2004
3Vascular Remodeling
01/2021 - 12/2019
3Insulin Resistance
01/2021 - 01/2011
3B-Cell Lymphoma (Lymphoma, B Cell)
12/2020 - 01/2017
3Hyperglycemia
03/2020 - 12/2011
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 04/2008
3Cerebral Infarction
10/2019 - 12/2014
3Lung Neoplasms (Lung Cancer)
09/2019 - 04/2008
3Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 01/2002
3Diabetes Mellitus
09/2017 - 12/2005
3Hyperalgesia
01/2017 - 11/2004
3Visceral Pain
01/2011 - 04/2007
2Brain Injuries (Brain Injury)
04/2022 - 12/2015
2Thrombocytopenia (Thrombopenia)
01/2022 - 10/2016

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
07/2022 - 11/2003
11Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2008
10Pharmaceutical PreparationsIBA
09/2021 - 02/2010
10Capsaicin (Zostrix)FDA Link
09/2015 - 02/2003
9LigandsIBA
10/2021 - 10/2002
8Long Noncoding RNAIBA
08/2022 - 02/2016
8Messenger RNA (mRNA)IBA
01/2018 - 02/2009
6GemcitabineFDA Link
01/2022 - 10/2016
6LipidsIBA
08/2021 - 12/2005
6Glucose (Dextrose)FDA LinkGeneric
03/2021 - 12/2011
6MicroRNAs (MicroRNA)IBA
01/2021 - 09/2012
6CytokinesIBA
03/2020 - 09/2007
6Peptides (Polypeptides)IBA
07/2018 - 04/2004
5Liposomes (Liposome)IBA
01/2022 - 10/2018
5Fluorouracil (Carac)FDA LinkGeneric
10/2021 - 04/2003
5Oxygen (Dioxygen)IBA
03/2021 - 02/2013
5ResistinIBA
01/2021 - 12/2019
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2020 - 03/2006
5Blood Glucose (Blood Sugar)IBA
03/2020 - 09/2014
4NF-kappa B (NF-kB)IBA
01/2022 - 10/2009
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021 - 05/2004
4Cisplatin (Platino)FDA LinkGeneric
10/2021 - 08/2008
4Phenobarbital (Luminal)FDA Link
11/2020 - 06/2014
4Paclitaxel (Taxol)FDA LinkGeneric
10/2020 - 01/2014
4EnzymesIBA
01/2020 - 02/2007
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020 - 12/2009
4HMGB1 Protein (HMG1)IBA
12/2019 - 05/2011
4Biological ProductsIBA
08/2015 - 09/2004
3C-Reactive ProteinIBA
01/2022 - 07/2012
3Benzyl Alcohol (Benzenemethanol)FDA Link
12/2021 - 06/2017
3IntegrinsIBA
01/2021 - 10/2019
3Antiviral Agents (Antivirals)IBA
01/2021 - 04/2013
3SolutionsIBA
03/2020 - 12/2014
3ChemokinesIBA
01/2020 - 03/2011
3Neuroprotective AgentsIBA
10/2019 - 12/2015
3UbiquitinIBA
07/2019 - 02/2014
3Hormones (Hormone)IBA
01/2017 - 10/2007
3Estrogen ReceptorsIBA
01/2017 - 01/2013
3Toll-Like Receptors (Toll-Like Receptor)IBA
02/2013 - 06/2010
3Anticonvulsants (Antiepileptic Drugs)IBA
02/2012 - 10/2008
3Insulin-Like Growth Factor I (IGF-1)IBA
12/2011 - 10/2007
3Protein Kinase CIBA
01/2011 - 10/2008
3AntigensIBA
06/2010 - 04/2004
3Calcitonin Gene-Related PeptideIBA
02/2009 - 11/2004
3NeuropeptidesIBA
02/2009 - 10/2007
2Polysaccharides (Glycans)IBA
08/2022 - 01/2016
2Trastuzumab (Herceptin)FDA Link
04/2022 - 01/2017

Therapy/Procedure

29Therapeutics
04/2022 - 09/2004
19Drug Therapy (Chemotherapy)
04/2022 - 01/2002
5Immunotherapy
01/2022 - 04/2004
5Radiotherapy
03/2020 - 01/2006
5Intradermal Injections
09/2010 - 02/2003
3Lasers (Laser)
10/2021 - 06/2006
3Perioperative Period
08/2019 - 05/2017